Molecular Pain,
Journal Year:
2023,
Volume and Issue:
19
Published: May 29, 2023
Here,
we
present
evidence
showing
Piezo1
protein
expression
in
the
primary
sensory
neurons
(PSNs)
and
non-neuronal
cells
of
rat
peripheral
nervous
system.
Using
a
knockdown/knockout
validated
antibody,
detected
immunoreactivity
(IR)
∼60%
PSNs
dorsal
root
ganglia
(DRG)
with
higher
IR
density
small-
medium-sized
neurons.
Piezo1-IR
was
clearly
identified
DRG
perineuronal
glia,
including
satellite
glial
(SGCs)
Schwann
cells;
sciatic
nerve
surrounding
axons
cutaneous
afferent
endings;
skin
epidermal
Merkel
melanocytes.
Neuronal
channels
were
functional
since
various
(dissociated
SGCs
from
DRGs,
isolated
cells,
human
melanocytes)
exhibited
robust
response
to
agonist
Yoda1
by
an
increase
intracellular
Ca
2+
concentration
([Ca
]
i
).
These
responses
abolished
non-specific
antagonist
GsMTx4.
Immunoblots
showed
elevated
proximal
injury-induced
painful
neuropathy,
while
rats
neuropathic
pain
greater
Yoda1-evoked
elevation
[Ca
increased
frequency
responding
Yoda1,
compared
controls.
Sciatic
application
GsMTx4
alleviated
mechanical
hypersensitivity
induced
Yoda1.
Overall,
our
data
show
that
is
widely
expressed
neuronal
pathways
injury
appeared
associated
activation
cells.
Physiological Reviews,
Journal Year:
2019,
Volume and Issue:
100(3), P. 945 - 982
Published: Dec. 23, 2019
Itch
is
a
topic
to
which
everyone
can
relate.
The
physiological
roles
of
itch
are
increasingly
understood
and
appreciated.
pathophysiological
consequences
impact
quality
life
as
much
pain.
These
dynamics
have
led
deep
dives
into
the
mechanisms
that
underlie
contribute
sensation
itch.
When
prior
review
on
physiology
itching
was
published
in
this
journal
1941,
black
box
interest
small
number
neuroscientists
dermatologists.
now
appreciated
complex
colorful
Rubik’s
cube.
Acute
chronic
being
carefully
scratched
apart
reassembled
by
puzzle
solvers
across
biomedical
spectrum.
New
mediators
identified.
Mechanisms
blur
boundaries
circuitry
blend
neuroscience
immunology.
Measures
involve
psychophysics
behavioral
psychology.
efforts
associated
with
these
approaches
positively
impacting
care
itchy
patients.
There
potential
markedly
alleviate
itch,
condition
does
not
end
life,
but
often
ruins
it.
We
field
provide
current
understanding
pathophysiology
disease,
only
symptom
disease.
Brain,
Journal Year:
2021,
Volume and Issue:
144(6), P. 1632 - 1645
Published: March 9, 2021
Peripheral
neuropathy
is
one
of
the
most
common
complications
both
type
1
and
2
diabetes.
Up
to
half
patients
with
diabetes
develop
during
course
their
disease,
which
accompanied
by
neuropathic
pain
in
30-40%
cases.
nerve
injury
can
manifest
as
progressive
distal
symmetric
polyneuropathy,
autonomic
neuropathy,
radiculo-plexopathies,
mononeuropathies.
The
diabetic
we
will
refer
DN,
its
characteristic
glove
stocking
like
presentation
sensory
or
motor
function
loss.
DN
painful
counterpart,
are
associated
increased
mortality
morbidity;
thus,
early
recognition
preventive
measures
essential.
Nevertheless,
it
not
easy
diagnose
particularly
mild
there
currently
no
single
established
diagnostic
gold
standard.
approach
research
a
hierarchical
system,
combines
symptoms,
signs,
series
confirmatory
tests.
general
lack
long-term
prospective
studies
has
limited
evaluation
sensitivity
specificity
new
morphometric
neurophysiological
techniques.
Thus,
best
paradigm
for
screening
clinical
practice
remains
uncertain.
Herein,
review
challenges
from
perspectives
implications
managing
DN.
There
treatment,
apart
improved
glycaemic
control,
more
effective
than
diabetes,
only
symptomatic
management
available
Currently,
less
one-third
derive
sufficient
relief
existing
pharmacotherapies.
A
precise
distinct
profile
may
help
identify
responsive
treatment
versus
another.
Detailed
profiles
lead
tailored
patient
subgroups
matching
novel
pathomechanisms
also
trials
stratification.
Large
randomized
needed
interventions,
i.e.
pharmacological,
physical,
cognitive,
educational,
etc.,
therapeutic
outcomes.
Brain,
Journal Year:
2021,
Volume and Issue:
144(5), P. 1312 - 1335
Published: Feb. 10, 2021
Abstract
Chronic
pain
affects
one
in
five
of
the
general
population
and
is
third
most
important
cause
disability-adjusted
life-years
globally.
Unfortunately,
treatment
remains
inadequate
due
to
poor
efficacy
tolerability.
There
has
been
a
failure
translating
promising
preclinical
drug
targets
into
clinic
use.
This
reflects
challenges
across
whole
development
pathway,
from
models
trial
design.
Nociceptors
remain
an
attractive
therapeutic
target:
their
sensitization
makes
contribution
many
chronic
states,
they
are
located
outside
blood–brain
barrier,
relatively
specific.
The
past
decade
seen
significant
advances
techniques
available
study
human
nociceptors,
including:
use
corneal
confocal
microscopy
biopsy
samples
observe
nociceptor
morphology,
culture
nociceptors
(either
surgical
or
post-mortem
tissue
using
induced
pluripotent
stem
cell
derived
nociceptors),
application
high
throughput
technologies
such
as
transcriptomics,
vitro
vivo
electrophysiological
characterization
through
microneurography,
correlation
with
percepts
provided
by
quantitative
sensory
testing.
Genome
editing
cell-derived
enables
interrogation
causal
role
genes
regulation
function.
Both
rodent
more
heterogeneous
at
molecular
level
than
previously
appreciated,
while
we
find
that
there
broad
similarities
between
also
differences
involving
ion
channel
function,
expression,
cellular
excitability.
These
technological
have
emphasized
maladaptive
plastic
changes
occurring
following
injury
contribute
pain.
Studying
revealed
new
for
suppression
enhanced
repair.
Cellular
enabled
screening
small
molecule
gene
therapy
approaches
on
some
cases
clinical
outcomes.
Undoubtedly,
remain.
Many
these
difficult
implement
scale,
current
differentiation
protocols
do
not
generate
full
diversity
populations,
still
understanding
inter-individual
variation
factors
age,
sex,
ethnicity.
We
hope
our
ability
directly
investigate
will
only
aid
fundamental
neurobiology
underlying
acute
but
help
bridge
translational
gap.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Feb. 3, 2022
Abstract
Efficacy
of
monoclonal
antibodies
against
calcitonin
gene-related
peptide
(CGRP)
or
its
receptor
(calcitonin
receptor-like
receptor/receptor
activity
modifying
protein-1,
CLR/RAMP1)
implicates
peripherally-released
CGRP
in
migraine
pain.
However,
the
site
and
mechanism
CGRP-evoked
peripheral
pain
remain
unclear.
By
cell-selective
RAMP1
gene
deletion,
we
reveal
that
released
from
mouse
cutaneous
trigeminal
fibers
targets
CLR/RAMP1
on
surrounding
Schwann
cells
to
evoke
periorbital
mechanical
allodynia.
activation
human
generates
long-lasting
signals
endosomes
cAMP-dependent
formation
NO.
NO,
by
gating
cell
transient
potential
ankyrin
1
(TRPA1),
releases
ROS,
which
a
feed-forward
manner
sustain
allodynia
via
nociceptor
TRPA1.
When
encapsulated
into
nanoparticles
release
cargo
acidified
endosomes,
antagonist
provides
superior
inhibition
signaling
mice.
Our
data
suggest
CGRP-mediated
neuronal/Schwann
pathway
mediates
associated
with
neurogenic
inflammation,
contributing
algesic
action
Neurobiology of Disease,
Journal Year:
2022,
Volume and Issue:
176, P. 105952 - 105952
Published: Dec. 7, 2022
The
glial
cell
of
the
peripheral
nervous
system
(PNS),
Schwann
(SC),
counts
among
most
multifaceted
cells
body.
During
development,
SCs
secure
neuronal
survival
and
participate
in
axonal
path
finding.
Simultaneously,
they
orchestrate
architectural
set
up
developing
nerves,
including
blood
vessels
endo-,
peri-
epineurial
layers.
Perinatally,
rodents,
radially
sort
subsequently
myelinate
individual
axons
larger
than
1
μm
diameter,
while
small
calibre
become
organised
non-myelinating
Remak
bundles.
have
a
vital
role
maintaining
health
throughout
life
several
specialized
SC
types
perform
essential
functions
at
specific
locations,
such
as
terminal
neuromuscular
junction
(NMJ)
or
within
cutaneous
sensory
end
organs.
In
addition,
neural
crest
derived
satellite
glia
maintain
tight
communication
with
soma
sensory,
sympathetic,
parasympathetic
neurons
derivatives
are
furthermore
an
indispensable
part
enteric
system.
remarkable
plasticity
becomes
evident
context
nerve
injury,
where
transdifferentiate
into
intriguing
repair
cells,
which
regenerative
response
that
promotes
repair.
Indeed,
multiple
adaptations
captivating,
but
remain
often
ill-resolved
on
molecular
level.
Here,
we
summarize
discuss
knowns
unknowns
vast
array
this
single
type
can
cover
maintenance,
Nature,
Journal Year:
2022,
Volume and Issue:
606(7912), P. 137 - 145
Published: May 25, 2022
Abstract
Nerve
injury
leads
to
chronic
pain
and
exaggerated
sensitivity
gentle
touch
(allodynia)
as
well
a
loss
of
sensation
in
the
areas
which
injured
non-injured
nerves
come
together
1–3
.
The
mechanisms
that
disambiguate
these
mixed
paradoxical
symptoms
are
unknown.
Here
we
longitudinally
non-invasively
imaged
genetically
labelled
populations
fibres
sense
noxious
stimuli
(nociceptors)
(low-threshold
afferents)
peripherally
skin
for
longer
than
10
months
after
nerve
injury,
while
simultaneously
tracking
pain-related
behaviour
same
mice.
Fully
denervated
initially
lost
sensation,
gradually
recovered
normal
developed
marked
allodynia
aversion
several
injury.
This
reinnervation-induced
neuropathic
involved
nociceptors
sprouted
into
territories
precisely
reproducing
initial
pattern
innervation,
were
guided
by
blood
vessels
showed
irregular
terminal
connectivity
lowered
activation
thresholds
mimicking
low-threshold
afferents.
By
contrast,
afferents—which
normally
mediate
intact
4–7
—did
not
reinnervate,
leading
an
aberrant
innervation
tactile
end
organs
such
Meissner
corpuscles
with
alone.
Genetic
ablation
fully
abrogated
reinnervation
allodynia.
Our
results
thus
reveal
emergence
form
is
driven
structural
plasticity,
abnormal
malfunction
during
reinnervation,
provide
mechanistic
framework
sensory
manifestations
observed
clinically
can
impose
heavy
burden
on
patients.
Nanoscale,
Journal Year:
2022,
Volume and Issue:
14(6), P. 2316 - 2326
Published: Jan. 1, 2022
Capable
of
reflecting
the
location
and
intensity
external
harmful
stimuli,
a
nociceptor
network
is
great
importance
for
receiving
pain-perception
information.
However,
hardware-based
implementation
through
use
transistor
array
remains
challenge
in
area
brain-inspired
neuromorphic
applications.
Herein,
simple
ionotronic
junctionless
oxide
with
abilities
successfully
realized
due
to
coplanar-gate
proton-coupling
effect
sodium
alginate
biopolymer
electrolyte.
Several
important
characteristics
nociceptors
are
emulated,
such
as
pain
threshold,
memory
prior
injury,
sensitization
behavior
pathway
alterations.
In
particular,
good
graded
system
has
been
established
coplanar
capacitance
resistance.
More
importantly,
clear
polarity
reversal
Lorentz-type
spatiotemporal
emulation
can
be
finally
our
projection-dependent
network.
This
work
may
provide
new
avenues
bionic
medical
machines
humanoid
robots
based
on
these
intriguing
abilities.